CMA announces Approval of Registration and IPO of Almoosa Health Company’s Shares

The Capital Market Authority (“CMA”) Board has issued its resolution dated 30/09/2024 approving Almoosa Health’s (“the company”) application for the Registration and the offering of (13,291,074) shares representing (30%) of the Company’s share capital. The Company’s prospectus will be published within sufficient time before the start of the subscription period.

The prospectus includes all relevant information the investor needs to know before making an investment decision, including the Company’s financial statements, activities and management.

A subscription decision without reading the prospectus carefully or thoroughly reviewing its content may involve high risk. Therefore, investors should carefully read the prospectus, which includes detailed information on the company, the offering and risk factors. Thus, it provides potential investors with the ability to evaluate the viability of investing in the offering, considering the associated risks. If the prospectus proves challenging to understand, consulting with an authorized financial advisor before making any investment decision is recommended.

The CMA’s approval of the application should never be considered a recommendation to subscribe to any specific company’s offering. It merely means that the legal requirements as per the Capital Market Law and its Implementing Regulations have been met.

The CMA’s application approval shall be valid for (6) months from the CMA Board resolution date. The approval shall be deemed cancelled if the offering and listing of the Company’s shares are not completed within this period.​